Real world study on the efficacy and safety of Shenqi Jiangtang tablets in the treatment of type 2 diabetes mellitus
Phase 4
Recruiting
- Conditions
- Type 2 diabetes
- Registration Number
- ITMCTR2100004820
- Lead Sponsor
- People's Hospital of Wuhan University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Patients who met the diagnostic criteria of Chinese guidelines for the prevention and treatment of type 2 diabetes (2017 Edition);
2. Aged 18-75 years;
3. 7% < HbA1c <= 10%;
4. Patients agreed and signed informed consent.
Exclusion Criteria
1. Blood glucose >= 13.57mmol/l;
2. Abnormal liver and kidney function: ALT or ast > 2 x ULN or TBIL > 2 x ULN; Cr > 1 x ULN or CCR < 60ml / min;
3. Pregnant or lactating women within half a year;
4. Allergic constitution or known allergy to the drugs and their components used in this test;
5. Patients considered unsuitable by the researchers.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method proportion of HbA1c<=7%;HbA1c;FPG;
- Secondary Outcome Measures
Name Time Method